Skip to main content
. 2015 May 13;11(6):1507–1517. doi: 10.1080/21645515.2015.1029686

Figure 2.

Figure 2.

(A) Percentage of subjects (95% CI) with seroresponse and percentage of subjects (95% CI) with hSBA titers ≥8 against serogroups ACWY at one month after first dose (Day 31) and 1 month after the second dose (Day 91), by vaccination group. (B) hSBA geometric mean titers (95% CI) against serogroups ACWY at baseline (Day 1) and one month after the first and second doses, by vaccination group.